Marksans Pharma (NSE:MARKSANS) 3-Year Book Growth Rate : 36.00% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma 3-Year Book Growth Rate?

Marksans Pharma's Book Value per Share for the quarter that ended in Dec. 2023 was ₹0.00.

During the past 12 months, Marksans Pharma's average Book Value per Share Growth Rate was 34.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was 36.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was 28.70% per year. During the past 10 years, the average Book Value per Share Growth Rate was 26.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Marksans Pharma was 69.20% per year. The lowest was -20.00% per year. And the median was 13.60% per year.

Competitive Comparison of Marksans Pharma's 3-Year Book Growth Rate

For the Drug Manufacturers - General subindustry, Marksans Pharma's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marksans Pharma's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's 3-Year Book Growth Rate falls into.

Marksans Pharma 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Marksans Pharma (NSE:MARKSANS) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Marksans Pharma 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Marksans Pharma (NSE:MARKSANS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

524404:India

Address

Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053

Website

http://www.marksanspharma.com

Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines